Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Atopic Eczema”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05544591
What this trial is testing

Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 93
Testing effectiveness (Phase 2)Looking for participantsNCT06947993
What this trial is testing

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 224
Testing effectiveness (Phase 2)Study completedNCT05277571
What this trial is testing

A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)

Who this might be right for
Atopic Dermatitis
UCB Biopharma SRL 109
Testing effectiveness (Phase 2)Study completedNCT05375955
What this trial is testing

Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Who this might be right for
Atopic DermatitisPlaque Psoriasis
Pfizer 263
Not applicableUnknownNCT03795506
What this trial is testing

TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)

Who this might be right for
Atopic Dermatitis Eczema
Imperial College London 96
Not applicableActive Not RecruitingNCT07582237
What this trial is testing

Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106)

Who this might be right for
Dermatitis, Atopic
Kang Stem Biotech Co., Ltd. 262
Testing effectiveness (Phase 2)Study completedNCT03443024
What this trial is testing

Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 280
Testing effectiveness (Phase 2)Study completedNCT06283550
What this trial is testing

Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

Who this might be right for
Chronic Hand Eczema
Innovaderm Research Inc. 82
Large-scale testing (Phase 3)Study completedNCT03738397
What this trial is testing

Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 673
Post-approval studies (Phase 4)Active Not RecruitingNCT05983068
What this trial is testing

Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis

Who this might be right for
Dermatitis Atopic
Sanofi 48
Large-scale testing (Phase 3)Looking for participantsNCT07711418
What this trial is testing

Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Moderate-to-Severe Atopic Dermatitis
Nektar Therapeutics 510
Testing effectiveness (Phase 2)Study completedNCT02426359
What this trial is testing

Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients

Who this might be right for
Moderate to Severe Atopic Dermatitis
Qurient Co., Ltd. 57
Testing effectiveness (Phase 2)Study completedNCT06101823
What this trial is testing

Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe AD (Atopic Dermatitis)

Who this might be right for
Atopic Dermatitis
Insmed Incorporated 50
Not applicableStudy completedNCT01714245
What this trial is testing

Evaluate CLn® BodyWash As Added Therapy in Eczema Patients

Who this might be right for
EczemaAtopic Dermatitis
TopMD Skin Care, Inc. 50
Not applicableLooking for participantsNCT05391061
What this trial is testing

Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 1,100
Testing effectiveness (Phase 2)Looking for participantsNCT06397911
What this trial is testing

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Oneness Biotech Co., Ltd. 114
Not applicableEnded earlyNCT02634905
What this trial is testing

Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months

Who this might be right for
Dermatitis, Atopic
Nantes University Hospital 178
Testing effectiveness (Phase 2)Study completedNCT06713499
What this trial is testing

A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Children and Adolescents With Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd 51
Testing effectiveness (Phase 2)Looking for participantsNCT06947980
What this trial is testing

Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Keymed Biosciences Co.Ltd 200
Large-scale testing (Phase 3)Looking for participantsNCT06311682
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
LEO Pharma 195
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation